TOVIAZ

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Spain, Turkey, UK.

Active ingredients

The drug TOVIAZ contains one active pharmaceutical ingredient (API):

1	Fesoterodine UNII EOS72165S7 - FESOTERODINE FUMARATE
	Fesoterodine is a competitive, specific muscarinic receptor antagonist. It is rapidly and extensively hydrolysed by non-specific plasma esterases to the 5-hydroxymethyl derivative, its primary active metabolite, which is the main active pharmacological principle of fesoterodine.
	Read more about Fesoterodine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TOVIAZ Prolonged-release tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BD11	Fesoterodine	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02380021, 02380048
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00020511, 00020540, 00568640, 00571808, 05450624, 05450653, 05892339, 05892397, 06130560, 06562271, 06575380, 06575397, 08844074, 08844097, 09196157, 09442509, 10796336, 10796342, 11227296, 13892483, 13892750, 14046187
EE	Ravimiamet	1294534, 1294545, 1294556, 1294567, 1294578, 1294589, 1294590, 1294602, 1294613, 1294624, 1462553, 1462564, 1462575, 1462586, 1462597, 1462609, 1462610, 1462621
ES	Centro de información online de medicamentos de la AEMPS	07386003, 07386008, 07386008IP, 07386008IP1, 07386008IP2
FI	Lääkealan turvallisuus- ja kehittämiskeskus	116694, 116705, 116716, 116727
FR	Base de données publique des médicaments	66259498, 68479557
GB	Medicines & Healthcare Products Regulatory Agency	136181, 136184, 196212, 375514, 381392
IE	Health Products Regulatory Authority	13215, 13216, 47505, 47506, 47526, 47527, 47553, 47575
IL	מִשְׂרַד הַבְּרִיאוּת	6261, 6262
IT	Agenzia del Farmaco	038699017, 038699029, 038699031, 038699043, 038699056, 038699068, 038699070, 038699082, 038699094, 038699106, 038699118, 038699120, 038699132, 038699144, 038699157, 038699169, 038699171, 038699183, 038699195, 038699207
JP	医薬品医療機器総合機構	2590015G1021, 2590015G2028
LT	Valstybinė vaistų kontrolės tarnyba	1031299, 1031300, 1031301, 1031302, 1031303, 1031304, 1031305, 1031306, 1031307, 1031308, 1036072, 1036073, 1036074, 1036075, 1036076, 1036077, 1054667, 1054668, 1068266, 1068267
NL	Z-Index G-Standaard, PRK	86258, 86266
PL	Rejestru Produktów Leczniczych	100180980, 100180996
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308030511, 8681308035127, 8681308035141, 8681308035790, 8681308035806, 8681308039514
US	FDA, National Drug Code	0069-0242, 0069-0244, 55154-2737, 55154-2738, 63539-183, 63539-242